title: Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
authors: Sherman Fertility Institute, Golda Meir Medical Center, Petah-Tikva, Israel.
authors: J
authors: J
authors: Ashkenazi
authors: J A
authors: JA
authors: Goldman
authors: D
authors: D
authors: Dicker
authors: D
authors: D
authors: Feldberg
authors: G A
authors: GA
authors: Goldman
mesh_terms: D000328:Adult; D002064:Buserelin / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008186:Luteolytic Agents / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D010062:Ovulation Induction; D017329:Triptorelin Pamoate
chemical_list: D008186:Luteolytic Agents; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin